Definitive Healthcare (DH) Q2 FY26 earnings call

Definitive Healthcare reported Q2 FY26 results in line with revenue guidance and above profit expectations, driven by effective expense management and strong cash flow generation. While total revenue declined and the life sciences segment showed slower improvement, the company highlighted a second consecutive quarter of year-over-year net dollar retention rate improvement and the strategic launch of its AI-powered Turbo platform, aiming to enhance customer value and drive future growth.